Persistent Depressive Disorders
1st Edition
Published on 13. May 2019
VI, 106 pages
978-1-61334-505-4 (ISBN)
Description
This compact guide is packed with the latest knowledge on the assessment and treatment of persistent depressive disorders (PDDs)
- the new DSM-5 diagnosis that amalgamates the categories dysthymic disorder (DD), chronic major depression (MDD), and DD with
major depressive episode (MDE).
Written by a leading expert, the book guides us through the complexities of assessing PDDs and the models for understanding how
these difficult-to-identify and potentially life-threatening disorders develop and are maintained over long periods. It then outlines
those therapies that have the strongest evidence base. The author goes on to explore in detail the cognitive behavioral analysis system
of psychotherapy (CBASP), a treatment specifically developed for PDDs. This compelling integrated approach incorporates components
of learning, developmental, interpersonal, and cognitive theory with aspects of interpersonal mindfulness. We are led expertly
through the therapeutic process using clinical vignettes and practical tips, with particular attention paid to identifying the assessment
and therapy methods most valuable in CBASP. Printable tools in the appendices can be used in daily practice.
This book will interest clinical psychologists, psychotherapists, psychiatrists, counselors, and students.
Reviews / Votes
Prof. Penberthy has written an excellent overview of the recent chronic depression category in DSM-5, persistent depressive disorder (PDD), reviewing a highly relevant body of literature and providing extensive summaries of empirically validated treatments. This text is a must-read for psychiatric and psychological practitioners and researchers, as well as anyone who is interested in depression, its biological, psychological, and genetic features, and clinical course."; James P. McCullough, Jr, PhD, Emeritus Professor of Psychology, Virginia Commonwealth University, Richmond, VAMore details
Series
Edition
2019
Language
English
Place of publication
Cambridge
United States
Target group
Professional and scholarly
College/higher education
Clinical psychologists, psychiatrists, psychotherapists, and counselors, as well as students.
File size
2,08 MB
ISBN-13
978-1-61334-505-4 (9781613345054)
DOI
10.1027/00505-000
Schweitzer Classification
Other editions
Additional editions
J. Kim Penberthy
Persistent Depressive Disorders
E-Book
05/2019
1st Edition
Hogrefe Publishing
€21.99
Available for download
J. Kim Penberthy
Persistent Depressive Disorders
Book
05/2019
1st Edition
Hogrefe Publishing
from
€24.95
Shipment within 3-4 weeks
Person
Dr. J. Kim Penberthy is the Chester F. Carlson Professor of Psychiatry & Neurobehavioral Sciences at the University of Virginia School of Medicine in Charlottesville, VA. She has spent her career treating patients with depressive disorders, training other professionals regarding effective treatments, and conducting research in the effective diagnosis and treatment of depression and related disorders. Dr. Penberthy is internationally known for her research regarding effective treatment for persistent depression and related disorders using the cognitive behavioral analysis system of psychotherapy (CBASP) and has developed applications for comorbidities and group administration.
Content
1 Description of Persistent Depressive Disorders
1.1 Terminology
1.2 Definition
1.3 Epidemiology
1.3.1 Gender and Sex Differences
1.3.2 Age
1.3.3 Ethnicity and Cultural and Socioeconomic Differences
1.4 Course and Prognosis
1.4.1 Dysthymic Disorder: Course
1.4.2 Major Depressive Disorder: Course
1.4.3 Onset Age
1.4.4 Impact of Treatment on Clinical Course
1.5 Differential Diagnosis
1.6 Comorbidities
1.7 Diagnostic Procedures and Documentation
1.7.1 Diagnostic Interviews
1.7.2 Clinician Rating Scales
1.7.3 Self-Report Scales
1.7.4 Scales Assessing Constructs Related to PDD
2 Theories and Models of Persistent Depressive Disorders
2.1 Biological Models
2.1.1 Genetics
2.1.2 Monoamine Hypothesis
2.1.3 Serotonin
2.1.4 Dopamine
2.1.5 Brain-Derived Neurotrophic Factor
2.1.6 Neuroendocrine Models
2.1.7 Glutamate
2.1.8 Brain Structure
2.2 Psychological Models
2.2.1 Interpersonal Models
2.2.2 Learning and Behavioral Models
2.2.3 Cognitive and Integrative Models
2.2.4 Mindfulness-Based Models
3 Diagnosis and Treatment Indications
3.1 Motivation or Readiness to Change
3.2 Longitudinal Life Course
3.3 Symptom Severity and Suicide Risk
3.4 Onset Age
3.5 Trauma History
3.6 Co-occurring Disorders or Medical Comorbidities
4 Treatment
4.1 Methods of Treatment
4.1.1 Interpersonal Psychotherapy
4.1.2 Cognitive Behavior Therapy
4.1.3 Cognitive Behavioral Analysis System of Psychotherapy
4.1.4 Mindfulness-Based Cognitive Therapy
4.1.5 Pharmacotherapy
4.2 Variations and Combinations of Methods
4.3 Problems in Carrying Out Treatments
4.4 Multicultural Issues
5 Further Reading
6 References
8 Appendix: Tools and Resources
1.1 Terminology
1.2 Definition
1.3 Epidemiology
1.3.1 Gender and Sex Differences
1.3.2 Age
1.3.3 Ethnicity and Cultural and Socioeconomic Differences
1.4 Course and Prognosis
1.4.1 Dysthymic Disorder: Course
1.4.2 Major Depressive Disorder: Course
1.4.3 Onset Age
1.4.4 Impact of Treatment on Clinical Course
1.5 Differential Diagnosis
1.6 Comorbidities
1.7 Diagnostic Procedures and Documentation
1.7.1 Diagnostic Interviews
1.7.2 Clinician Rating Scales
1.7.3 Self-Report Scales
1.7.4 Scales Assessing Constructs Related to PDD
2 Theories and Models of Persistent Depressive Disorders
2.1 Biological Models
2.1.1 Genetics
2.1.2 Monoamine Hypothesis
2.1.3 Serotonin
2.1.4 Dopamine
2.1.5 Brain-Derived Neurotrophic Factor
2.1.6 Neuroendocrine Models
2.1.7 Glutamate
2.1.8 Brain Structure
2.2 Psychological Models
2.2.1 Interpersonal Models
2.2.2 Learning and Behavioral Models
2.2.3 Cognitive and Integrative Models
2.2.4 Mindfulness-Based Models
3 Diagnosis and Treatment Indications
3.1 Motivation or Readiness to Change
3.2 Longitudinal Life Course
3.3 Symptom Severity and Suicide Risk
3.4 Onset Age
3.5 Trauma History
3.6 Co-occurring Disorders or Medical Comorbidities
4 Treatment
4.1 Methods of Treatment
4.1.1 Interpersonal Psychotherapy
4.1.2 Cognitive Behavior Therapy
4.1.3 Cognitive Behavioral Analysis System of Psychotherapy
4.1.4 Mindfulness-Based Cognitive Therapy
4.1.5 Pharmacotherapy
4.2 Variations and Combinations of Methods
4.3 Problems in Carrying Out Treatments
4.4 Multicultural Issues
5 Further Reading
6 References
8 Appendix: Tools and Resources
